首页> PloS one> T cell mediated immunity after combination therapy with intralesional PV-10 and blockade of the PD-1/PD-L1 pathway in a murine melanoma model.

T cell mediated immunity after combination therapy with intralesional PV-10 and blockade of the PD-1/PD-L1 pathway in a murine melanoma model.

导出 OA

翻译打印收藏纠错

第一作者： Hao,Liu

第一单位： Department of Immunology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States of America.

作者： Hao,Liu ^[1] ; Amy,Weber ^[1] ; Jennifer,Morse ^[1] ; Krithika,Kodumudi ^[1] ; Ellen,Scott ^[1] ; John,Mullinax ^[2] ; Amod A,Sarnaik ^[3] ; Shari,Pilon-Thomas ^[3]

作者单位： Department of Immunology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States of America. ^[1] Department of Immunology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States of America.;Sarcoma Program, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States of America. ^[2] Department of Immunology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States of America.;Department of Cutaneous Oncology at H. Lee Moffitt Cancer and Research Institute Tampa, Florida, United States of America. ^[3]